These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7699675)

  • 1. Lichen planus in patients with rheumatoid arthritis treated with sulfasalazine.
    Kaplan S; McDonald E; Marino C
    J Rheumatol; 1995 Jan; 22(1):191-2. PubMed ID: 7699675
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfasalazine induced lichen planus in a patient of rheumatoid arthritis.
    Ghosh S; Jain VK; Chaudhuri S; Mathur SK
    Indian J Dermatol Venereol Leprol; 2013; 79(4):541-4. PubMed ID: 23760333
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lichenoid eruption during the treatment of rheumatoid arthritis with pyrithioxin].
    Crouzet J; Fourot J; Julie JH; Duterque M
    Rev Rhum Mal Osteoartic; 1983 Dec; 50(12):827-8. PubMed ID: 6229868
    [No Abstract]   [Full Text] [Related]  

  • 4. Late onset hypersensitivity to sulfasalazine in a patient with ankylosing spondylitis: comment on the article by Paul et al.
    Marino C; McDonald E
    Arthritis Care Res; 2000 Oct; 13(5):335; author reply 335. PubMed ID: 14635305
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome.
    Shenoy P; Misra R; Jain M; Agarwal V
    N Z Med J; 2008 Jun; 121(1276):102-5. PubMed ID: 18574514
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of sulfasalazine in the treatment of generalized lichen planus: randomized double-blinded clinical trial on 52 patients.
    Omidian M; Ayoobi A; Mapar MA; Feily A; Cheraghian B
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1051-4. PubMed ID: 20158586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity reaction to sulfasalazine: skin rash, fever, hepatitis and activated lymphocytes.
    Leroux JL; Ghezail M; Chertok P; Blotman F
    Clin Exp Rheumatol; 1992; 10(4):427. PubMed ID: 1356682
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal agranulocytosis in sulfasalazine treated rheumatoid arthritis.
    Guillemin F; Aussedat R; Guerci A; Lederlin P; Trechot P; Pourel J
    J Rheumatol; 1989 Aug; 16(8):1166-7. PubMed ID: 2573730
    [No Abstract]   [Full Text] [Related]  

  • 10. Lichen planus-like eruptions after INH and PAS.
    Haldar B
    Indian J Dermatol; 1974 Apr; 19(3):71-2. PubMed ID: 4279214
    [No Abstract]   [Full Text] [Related]  

  • 11. [Agranulocytosis in rheumatoid polyarthritis treated with sulfasalazine].
    Pointud P; Cauhape P; Favreau A
    Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):573. PubMed ID: 2569228
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulphasalazine desensitisation in patients with arthritis.
    McCarthy C; Coughlan R
    Ir J Med Sci; 1994 May; 163(5):238-9. PubMed ID: 7913919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfasalazine induced lupus in rheumatoid arthritis.
    Caulier M; Dromer C; Andrieu V; Le Guennec P; Fournie B
    J Rheumatol; 1994 Apr; 21(4):750-1. PubMed ID: 7913504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfasalazine-induced hypersensitivity syndrome in a 15-year-old boy associated with human herpesvirus-6 reactivation.
    Balci DD; Peker E; Duran N; Dogramaci CA
    Cutan Ocul Toxicol; 2009; 28(1):45-7. PubMed ID: 19514926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sulfasalazine-induced megaloblastic anemia in rheumatoid arthritis].
    López R; Cuquet J; Fitó R; Pujol R
    Med Clin (Barc); 1988 Oct; 91(14):559. PubMed ID: 2905757
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.
    Gran JT; Myklebust G
    Scand J Rheumatol; 1993; 22(5):229-32. PubMed ID: 7901898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lichenoid drug eruption caused by adalimumab: a case report and literature review.
    Inoue A; Sawada Y; Yamaguchi T; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Okada E; Nakamura M
    Eur J Dermatol; 2017 Feb; 27(1):69-70. PubMed ID: 27777187
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug rash with eosinophilia and systemic symptoms syndrome induced by sulfasalazine.
    Bahat G; Celik HG; Tufan F; Saka B
    Joint Bone Spine; 2010 Jan; 77(1):87-8. PubMed ID: 19854669
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulphasalazine in rheumatoid arthritis.
    Boey ML; Lee E; Feng PH
    Singapore Med J; 1988 Jun; 29(3):285-8. PubMed ID: 2903555
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of lichen planus with sulfasalazine in 20 patients.
    Bauzá A; España A; Gil P; Lloret P; Vázquez Doval FJ
    Int J Dermatol; 2005 Feb; 44(2):158-62. PubMed ID: 15689219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.